Hydrolytic Lysosomal Glucocerebroside-specific Enzyme class drugs

3 results
  • cerezyme

    (IMIGLUCERASE)
    Genzyme Corporation
    Cerezyme is indicated for the treatment of adults and children aged 2 years and older with Type 1 Gaucher disease, addressing conditions such as anemia, thrombocytopenia, bone disease, and hepatomegaly or splenomegaly.
  • elelyso

    (Taliglucerase alfa)
    Pfizer Laboratories Div Pfizer Inc
    ELELYSO is indicated for the treatment of adults and children aged 4 years and older who have a confirmed diagnosis of Type 1 Gaucher disease.
  • vpriv

    (velaglucerase alfa)
    Takeda Pharmaceuticals America, Inc.
    VPRIV is indicated for long-term enzyme replacement therapy in patients with type 1 Gaucher disease.